Measuring Psychosocial Risk in Families Caring for a Child With Cancer: The Psychosocial Assessment Tool (PAT2.0)
Measuring Psychosocial Risk in Families Caring for a Child With Cancer: The Psychosocial Assessment Tool (PAT2.0)
复制标题
DOI：
10.1002/pbc.22007
复制
发表时间：
2009-07-15
影响因子：
3.2
通讯作者：
Anderson, Vicki A.
中科院分区：
文献类型：
--
作者：
McCarthy, Maria C.;Clarke, Naomi E.;Anderson, Vicki A.
背景社会心理评估工具2.0（PAT2.0）是最近开发的筛查措施，用于评估照顾癌症儿童的家庭的社会心理风险。本研究旨在评估PAT2.0在澳大利亚儿科肿瘤样本中的外部效度。进一步的目标包括检查母亲和父亲的PAT2.0评分，心理社会风险随时间的变化，以及治疗强度和心理社会风险之间的关系。Procedure. 143名新诊断为癌症的儿童的父母在诊断时（T1）和6-8个月后（T2）完成了PAT2.0。由两名临床肿瘤学家完成治疗强度测量（ITR-2）。结果PAT2.0将家庭分为3层风险框架，与量表作者的现有数据一致。大多数家庭被分为普遍（最低风险）类别;超过三分之一的家庭有一些较高的心理社会风险。母亲和父亲的PAT2.0评分相关，心理社会风险在T1和T2之间保持相对稳定。治疗强度评分与T2时的PAT2.0评分无关。结论.结果支持外部效度的PAT2.0作为一个社会心理筛选。母亲和父亲的风险评级是相似的，但是，多信息使用PAT2.0可能是临床有用的。通过PAT2.0测量的心理社会风险在治疗的前几个月是一个相对稳定的结构，与治疗强度无关。儿科血液癌症2009;53：78-83. (C)2009 Wiley-Liss，Inc.
Background. The Psychosocial Assessment Tool 2.0 (PAT2.0) is a recently developed screening measure for assessing psychosocial risk in families caring for a child with cancer. This Study aimed to assess the external validity of the PAT2.0 in an Australian pediatric oncology sample. Further aims included examining mothers' and fathers' PAT2.0 scores, change in psychosocial risk over time, and the relationship between treatment intensity and psychosocial risk. Procedure. Parents of 143 children newly diagnosed with cancer completed the PAT2.0 at diagnosis (T1) and 6-8 months later (T2). A treatment intensity measure (ITR-2) was completed by two clinical oncologists. Results. The PAT2.0 stratified families into a 3-tiered risk framework and was consistent with existing data from the authors of the scale. The majority of families were stratified into the Universal (lowest risk) category; more than one-third of families had some elevated psychosocial risk. PAT2.0 scores of mothers and fathers were correlated and psychosocial risk remained relatively stable between T1 and T2. Treatment intensity scores were not related to PAT2.0 scores at T2. Conclusions. Findings Support the external validity of the PAT2.0 as a psychosocial screener. Mothers' and fathers' ratings of risk are similar; however, multi-informant use of the PAT2.0 may be clinically useful. Psychosocial risk, as measured by the PAT2.0, is a relatively stable construct over the first months of treatment and is independent of treatment intensity. Pediatr Blood Cancer 2009;53:78-83. (C) 2009 Wiley-Liss, Inc.